FDA to authorize booster vaccine dose for people with weak immune systems, and WHO to test 3 drugs as possible treatments for hospitalized COVID patients

The U.S. Food and Drug Administration is planning to authorize a third dose of the COVID-19 vaccine for people with weakened immune systems in a decision that could come as soon as Thursday, according to the New York Times, as the delta variant continues to spread fast across the U.S.